Dabigatran versus warfarin after mechanical mitral valve replacement in the swine model

Journal of Investigative Surgery

Volumn 25, Issue 3, 2012, Pages 150-155

  Schomburg, John L ^a   Medina, Eduardo M ^a   Lahti, Matthew T ^a   Bianco, Richard W ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Anticoagulation; Dabigatran; Mechanical valve replacement; Thrombin inhibitor

Indexed keywords

DABIGATRAN; HEPARIN; WARFARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DRUG DOSE TITRATION; FEMALE; IN VIVO STUDY; INTERNATIONAL NORMALIZED RATIO; MALE; MITRAL VALVE REPLACEMENT; NONHUMAN; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; SINGLE DRUG DOSE; SWINE; THROMBOSIS PREVENTION;

ANIMALS; ANTICOAGULANTS; BENZIMIDAZOLES; BETA-ALANINE; DRUG EVALUATION, PRECLINICAL; FEMALE; HEART VALVE PROSTHESIS; HEMORRHAGE; MALE; MITRAL VALVE; MODELS, ANIMAL; SUS SCROFA; THROMBOSIS; WARFARIN;

EID: 84861050486     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.3109/08941939.2011.616256     Document Type: Article

References (17)

1. Sun J, Davidson M, Lamy A, Eikelboom JW. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends. The Lancet. 2009; 374: 565-576.
2. Rahimtoola S. Choice of prosthetic heart valve in adults: an update. J Am Coll Cardiol. 2010; 55: 2413-2426.
3. Stangier J. Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. Clin Pharmacokinet. 2008; 47: 285-295. (Pubitemid 351508116)
4. Eikelboom J, Weitz J. Update on antithrombotic therapy: new anticoagulants. Circulation. 2010; 121: 1523-1532.
5. Connolly S, Ezekowitz M, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361: 1139-1151.
6. Maegdelfessel L, Linde T, Krapiec F, et al. In vitro comparison of dabigatran, unfractionated heparin, and low-molecular-weight heparin in preventing thrombus formation on mechanical heart valves. Thromb Res. 2010; 126: e196-e200.
7. United States Food and Drug Administration. Guidance for Industry and FDA Staff; General Considerations for Animal Studies for Cardiovascular Devices. July 29, 2010. Retrieved from: http: //www.fda.gov/medicaldevices/ deviceregulationandguidance/guidancedocuments/ ucm220760.htm
8. Carrier M, Pellerin M, Basmadjian A, et al. Fifteen years of clinical and echocardiographic follow up with the carbomedics heart valve. J Heart Valve Dis. 2006; 15: 67-72. (Pubitemid 43180527)
9. Grehan J, Hilbert S, Ferrans V, et al. Development and evaluation of a swine model to assess the preclinical safety of mechanical heart valves. J. Heart Valve Dis. 2000; 9: 710-719.
10. Iaizzo P. Handbook of Cardiac Anatomy, Physiology, and Devices, 2nd ed. New York, NY: Springer; 2009.
11. Li D, Ren BH, Shen Y, et al. A swine model for longterm evaluation of prosthetic heart valves. ANZ J Surg. 2007; 77: 654-658. (Pubitemid 47063353)
12. Dexter E, Aluri S, Radcliffe R, et al. In vivo demonstration of cavitation potential of a mechanical heart valve. ASAIO J. 1999; 45: 436-441. (Pubitemid 30116965)
13. Sato M, Harasaki H,Wika K, et al. Blood compatibility of a newly developed trileaflet mechanical heart valve. ASAIO J. 2003; 49: 117-122. (Pubitemid 36105590)
14. Bianco R, St Cyr J, Schneider J. et al. Canine model for long-term evaluation of prosthetic mitral valves. J Surg Res. 1986; 41: 134-140. (Pubitemid 16032190)
15. Irwin E, Lang G, Clack R. Long-term evaluation of prosthetic mitral valves in sheep. J Invest Surg. 1993; 6: 133-141. (Pubitemid 23189142)
16. Smerup M, Pedersen TF, Nyboe C, et al. A long-term porcine model for evaluation of prosthetic heart valves. Heart Surg Forum. 2004; 7: E259-E264.
17. Ma L, Tozzi P, Huber C. Double-crowned valved stents for off-pump mitral valve replacement. Eur J Cardiothorac Surg. 2005; 28: 194-199